U.S. Herd Immunity Could Be Coming by End of June
Limited vaccine supply in other countries could make global immunity tougher to achieve, though.
With 1.13 billion doses of coronavirus vaccines administered globally as of the end of April, the ramp-up in immunizations is well underway. In the United States, President Joe Biden targets July 4 for a return to near normal, which we think is feasible, given our assumption of potential herd immunity (through both infection and vaccination) by the end of June.
Outside the U.S., vaccinations have been delayed by manufacturing issues and rare side effects for adenoviral vector vaccines. The lower efficacy of non-mRNA vaccines and tougher distribution in developing markets make endemic virus more likely.
Karen Andersen does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.